Search clinical trials for: recurrent ovarian epithelial cancer
Total 96736 results
-
PhotonPharma, Inc.Not yet recruiting
-
ImmunoGen, Inc.Not yet recruitingRecurrent Ovarian Cancer | Folate Receptor-Alpha PositiveUnited States, Spain, Australia, Belgium, Canada, France, Ireland, Italy
-
Dana-Farber Cancer InstituteImmunityBio, Inc.Not yet recruitingOvarian Cancer | Platinum-resistant Ovarian Cancer | Ovarian Carcinoma | Recurrent Ovary Cancer | Ovarian Carcinoma, RecurrentUnited States
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingRecurrent Ovarian CancerChina
-
UNC Lineberger Comprehensive Cancer CenterNot yet recruitingOvarian Cancer | Epithelial Ovarian Cancer | Ovary Neoplasm | RecurrentUnited States
-
University of WashingtonNational Cancer Institute (NCI)RecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
The University of Hong KongRecruitingRecurrent Ovarian CarcinomaHong Kong
-
Eli Lilly and CompanyLoxo Oncology, Inc.RecruitingCervical Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Bladder Cancer | Triple Negative Breast Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Renal Pelvis Cancer | Urinary Bladder Neoplasm | Recurrent...United States
-
Chang Gung Memorial HospitalRecruiting
-
The First Affiliated Hospital of Xiamen UniversityNot yet recruiting
-
RemeGen Co., Ltd.Not yet recruitingPrimary Peritoneal Cancer | Fallopian Tube | Epithelial OvarianChina
-
Qilu Hospital of Shandong UniversityNot yet recruiting
-
Kancera ABNordic Society of Gynaecological Oncology - Clinical Trials UnitRecruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerDenmark, Norway, Sweden
-
Verastem, Inc.GOG Foundation; European Network of Gynaecological Oncological Trial Groups...RecruitingLow Grade Serous Ovarian CancerUnited States, Australia
-
Power Life Sciences Inc.Not yet recruitingRecurrent Ovarian CancerUnited States
-
A2 Biotherapeutics Inc.Tempus AIRecruitingCancer | Colorectal Cancer | Ovarian Neoplasms | Ovarian Cancer | NSCLC | Lung Cancer | Rectal Cancer | Non Small Cell Lung Cancer | Mesothelioma | Mesothelioma, Malignant | Colon Cancer | Pancreas Cancer | Colorectal Adenocarcinoma | Solid Tumor, Adult | CRC | Pancreatic Neoplasm | Ovary Cancer | NSCLC, Recurrent | Non-Small Cell... and other conditionsUnited States
-
Yonsei UniversityNot yet recruitingUterine Cervical Neoplasms | Ovarian Neoplasms | Endometrial Neoplasms | Vulvar Cancer | Clear Cell Carcinoma | Vagina Neoplasm
-
InxMed (Shanghai) Co., Ltd.Recruiting
-
Hebei Medical University Fourth HospitalNot yet recruiting
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation TrustNot yet recruitingOvarian Cancer RecurrentUnited Kingdom
-
National Cancer Institute (NCI)NRG OncologyRecruitingOvarian Endometrioid Adenocarcinoma | Endometrial Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Endometrioid Adenocarcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian High Grade Serous Adenocarcinoma | Platinum-Resistant Ovarian Carcinoma | Endometrial Low Grade Endometrioid... and other conditionsUnited States
-
Lan CoffmanNational Cancer Institute (NCI); MorphoSys AGRecruitingRecurrent Ovarian CancerUnited States
-
Mayo ClinicRecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Ovarian High Grade Serous Adenocarcinoma | Fallopian Tube Carcinosarcoma | Primary Peritoneal Carcinosarcoma | Recurrent Fallopian Tube Clear Cell Adenocarcinoma | Recurrent Fallopian... and other conditionsUnited States
-
Sapience TherapeuticsRecruitingHepatocellular Carcinoma | Pancreatic Cancer | Ovarian Cancer | Cholangiocarcinoma | Triple Negative Breast Cancer | Metastatic Melanoma | Colon Cancer | Synovial Sarcoma | Breast Cancer Metastatic | Metastatic Colon Cancer | Melanoma Stage IV | Melanoma Recurrent | TNBC - Triple-Negative Breast Cancer | NSCLC, Metastatic and other conditionsUnited States
-
Fudan UniversityNot yet recruitingRecurrent Ovarian CancerChina
-
NX Development CorpNot yet recruiting
-
M.D. Anderson Cancer CenterMereo BioPharmaRecruiting
-
OnxeoRecruitingBreast Cancer | Metastatic Castration-resistant Prostate Cancer | Recurrent Epithelial Ovarian CancerUnited States
-
National Cancer Institute (NCI)RecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Endometrial Carcinoma | Stage III Uterine Corpus Cancer AJCC v8 | Stage IV Uterine Corpus Cancer AJCC v8 | Recurrent Platinum-Resistant Ovarian Carcinoma | Metastatic Fallopian Tube Carcinoma | Metastatic Primary... and other conditionsUnited States
-
Tongji HospitalQilu Hospital of Shandong University; People's Hospital of Quzhou; Shenzhen Hua...Not yet recruiting
-
City of Hope Medical CenterNational Cancer Institute (NCI)Not yet recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Resistant Ovarian CarcinomaUnited States
-
Karyopharm Therapeutics IncGOG Foundation; European Network of Gynaecological Oncological Trial Groups... and other collaboratorsRecruitingEndometrial CancerUnited States, Belgium, Spain, Israel, Australia, Italy, Georgia, Ireland, Greece, Slovakia, Canada, Hungary, Czechia
-
Sham Sunder KakarUniversity of Louisville Health CareNot yet recruitingRecurrent Ovarian Cancer
-
Verismo TherapeuticsRecruitingOvarian Cancer | Mesothelioma, Malignant | Cholangiocarcinoma RecurrentUnited States
-
National Cancer Institute (NCI)RecruitingAnatomic Stage III Breast Cancer AJCC v8 | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Anatomic Stage IV Breast Cancer AJCC v8 | Advanced Malignant Solid Neoplasm | Locally Advanced Malignant Solid Neoplasm | Unresectable Malignant Solid... and other conditionsUnited States, Puerto Rico
-
National Cancer Institute (NCI)NRG OncologyRecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Endometrial CarcinomaUnited States, Puerto Rico
-
Chongqing University Cancer HospitalRecruiting
-
National Cancer Institute (NCI)NRG OncologyRecruitingRecurrent Endometrial Endometrioid Adenocarcinoma | Stage IV Uterine Corpus Cancer AJCC v8 | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma | Metastatic Endometrial Endometrioid AdenocarcinomaUnited States
-
ImmunoGen, Inc.RecruitingFallopian Tube Cancer | Endometrial Cancer | Primary Peritoneal Carcinoma | High Grade Serous Adenocarcinoma of OvaryUnited States
-
University of OklahomaGlaxoSmithKlineRecruitingRecurrent Ovarian Carcinoma | Recurrent Endometrial Carcinoma | ARID1A Gene MutationUnited States
-
Haider MahdiMerck Sharp & Dohme LLC; ALX OncologyRecruiting
-
Yonsei UniversityRecruitingOvarian CancerKorea, Republic of
-
Yonsei UniversityRecruitingRecurrent Epithelial Ovarian CancerKorea, Republic of
-
Zhongda HospitalNot yet recruitingOvarian Cancer, EpithelialChina
-
Peking Union Medical College HospitalZai Lab (Shanghai) Co., Ltd.Not yet recruiting
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingPlatinum-resistant Recurrent Ovarian CancerChina
-
H. Lee Moffitt Cancer Center and Research InstituteAnixa Biosciences, Inc.RecruitingOvarian CancerUnited States
-
National Cancer Center, KoreaRecruitingEpithelial Ovarian CancerKorea, Republic of
-
Lei LiRecruitingChemotherapy | Ovarian Carcinoma | Survival Outcomes | Adverse Events | Niraparib | Anlotinib | CA125 | Targeted Therapy | Recurrent Ovarian CancerChina
-
Lei LiRecruitingRecurrent Ovarian Carcinoma | Platinum-resistant Ovarian Cancer | Bevacizumab | Ovarian Carcinoma | Survival Outcomes | Adverse Events | Albumin-bound PaclitaxelChina